Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Novel Therapeutics and Targeted Therapies
    • +

      P50.05 - Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study

      00:00 - 00:00  |  Presenter: Madhusmita Behera

      • Abstract

      Loading...

  • +

    P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
    • +

      P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study

      00:00 - 00:00  |  Presenter: Paolo Bironzo

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      07:38 - 07:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.09 - International Association for the Study of Lung Cancer (IASLC) Study of the Impacts of COVID-19 on International Lung Cancer Clinical Trials

      15:38 - 15:48  |  Presenter: Matthew Smeltzer

      • Abstract

      Loading...

  • +

    JIES01 - Joint IASLC – ESTRO Session: Advances in Radiotherapy for Lung Cancer

    • 07:00 - 08:00
    • 9/10/2021
    • Location: Program Auditorium
    • Not for CME Credit
    • Type: Education Session
    • Track: N.A.
    • +

      JIES01.01 - RT in Oligometastatic Disease

      07:00 - 07:10  |  Presenter: Fiona Mary Alison McDonald

      • Abstract

      No abstract available for this presentation

    • +

      JIES01.02 - Radiomics and Radiotherapy: State of the Art and Future Challenges

      07:10 - 07:20  |  Presenter: Dirk De Ruysscher

      • Abstract

      Loading...

    • +

      JIES01.03 - Combining Radiotherapy and Immunotherapy

      07:20 - 07:30  |  Presenter: Corinne Faivre-Finn

      • Abstract

      No abstract available for this presentation

    • +

      JIES01.04 - Prophylactic Cranial Irradiation in Lung Cancer: Where We Are

      07:30 - 07:40  |  Presenter: Ben J. Slotman

      • Abstract

      Loading...

    • +

      JIES01.05 - Live Discussion with Speakers

      07:40 - 08:00

      • Abstract

      No abstract available for this presentation

  • +

    BEDG02 - Lung Ambition Alliance with AstraZeneca - Accelerating the Early Diagnosis of Lung Cancer at Local Level

    • 12:00 - 13:00
    • 9/10/2021
    • Location: Brain Exchange Lounge
    • Not for CME Credit
    • Type: Brain Exchange Discussion Groups
    • Track: N.A.
    • +

      BEDG02.01 - Welcome, Introductions and Session Overview

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.02 - Time for Screening of Lung Cancer is Now

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.03 - Challenges in LCS: How to Overcome Them

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.04 - IPN Detection as a Complementary Strategy

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.05 - Potential of AI in Early Lung Cancer Detection

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.06 - Case Studies/Best Practices

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

    • +

      BEDG02.07 - Discussion/Q&A

      12:00 - 12:00

      • Abstract

      No abstract available for this presentation

  • +

    GA01 - IASLC General Assembly

    • 15:00 - 16:00
    • 9/12/2021
    • Location: Program Auditorium
    • Type: Highlights
    • Track: N.A.
    • +

      GA01.03 - Scientific Activities Report

      15:00 - 15:00  |  Presenter: Giorgio Vittorio Scagliotti

      • Abstract

      No abstract available for this presentation

  • +

    MA12 - The Impact of COVID-19 on How We Treat Thoracic Cancer Now and in the Future

    • 20:00 - 21:00
    • 9/12/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Management of Lung Cancer in the Era of COVID-19
    • +

      MA12.07 - Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center

      20:40 - 20:45  |  Presenter: Maristella Bungaro

      • Abstract

      Loading...